Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PCC0208017

🥰Excellent
Catalog No. T40249Cas No. 2623158-64-3

PCC0208017 is an inhibitor of MARK3 and MARK4 with IC50s of 1.8 and 2.01 nM. PCC0208017 disrupts microtubule dynamics and displays potent antitumor activity.

PCC0208017

PCC0208017

🥰Excellent
Purity: 98.28%
Catalog No. T40249Cas No. 2623158-64-3
PCC0208017 is an inhibitor of MARK3 and MARK4 with IC50s of 1.8 and 2.01 nM. PCC0208017 disrupts microtubule dynamics and displays potent antitumor activity.
Pack SizePriceAvailabilityQuantity
1 mg$97In Stock
5 mg$239In Stock
10 mg$383In Stock
25 mg$712In Stock
50 mg$1,080In Stock
1 mL x 10 mM (in DMSO)$263In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "PCC0208017"

Select Batch
Purity:98.28%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
PCC0208017 is an inhibitor of MARK3 and MARK4 with IC50s of 1.8 and 2.01 nM. PCC0208017 disrupts microtubule dynamics and displays potent antitumor activity.
In vitro
PCC0208017 has much lower inhibitory activity against MARK1 and MARK2, with IC50s of 31.4 and 33.7 nM, respectively. PCC0208017 (1-5 μM) decreases the phosphorylation of Tau. PCC0208017 (3-21 μM) suppresses the proliferation of glioma cells[1].
In vivo
In C57BL/6 mice bearing murine glioma GL261 xenograft tumor, PCC0208017 (50 and 100 mg/kg; oral) dose-dependently inhibits the growth of xenograft tumors derived with inhibition rates of 56.15% and 70.32%, respectively. PCC0208017 (50 mg/kg; oral) exhibits Cmax and Tmax of 1.36 μg/mL and 0.833 h in plasma and 0.14 μg/mL and 0.833 h in brain[1]. Co-treatment of PCC0208017 (50 mg/kg) significantly enhances the anti-tumor activity of Temozolomide (100 mg/kg) with inhibition rates from 34.15% to 83.5%[1].
Chemical Properties
Molecular Weight403.4
FormulaC19H20F3N7
Cas No.2623158-64-3
SmilesCN1CCc2cc(Nc3ncc(c(NCc4cc[nH]n4)n3)C(F)(F)F)ccc2C1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 112.5 mg/mL (278.9 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4789 mL12.3946 mL24.7893 mL123.9465 mL
5 mM0.4958 mL2.4789 mL4.9579 mL24.7893 mL
10 mM0.2479 mL1.2395 mL2.4789 mL12.3946 mL
20 mM0.1239 mL0.6197 mL1.2395 mL6.1973 mL
50 mM0.0496 mL0.2479 mL0.4958 mL2.4789 mL
100 mM0.0248 mL0.1239 mL0.2479 mL1.2395 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PCC0208017 | purchase PCC0208017 | PCC0208017 cost | order PCC0208017 | PCC0208017 chemical structure | PCC0208017 in vivo | PCC0208017 in vitro | PCC0208017 formula | PCC0208017 molecular weight